Table 3 The COVID-19 health impact assessment results of individual reviewed studies
From: Disability-adjusted life years (DALYs) based COVID-19 health impact assessment: a systematic review
No. | Studies | Case rate measures | Standard life expectancy used | Result of individual studies | ||
|---|---|---|---|---|---|---|
YLDs | YLLs | DALYs | ||||
1. | Cuschieri et al. [9] | Incidence | GBD-2019 | 250 | 5, 229 | 5, 479 |
2. | Fan et al. [11] | Incidence | GBD-2017 | 4, 399 | 27, 531 | 31,930,000 |
3. | Oh et al. [12] | Incidence | GBD-2017 | 0 | 4,072,325 | 4,072,325 |
4. | Wyper et al. [13] | Incidence | GBD-2019 | 2, 048 | 100,333 | 102, 381 |
5. | Islam et al. [14] | Incidence | GBD-2010 | 0 | 28,100,000 | 28,100,000 |
6. | Pifarre et al. [15] | Incidence | GBD-2017 | 0 | 20,507,514 | 20,507,514 |
7. | Ugarte et al. [16] | Incidence | GBD-2017 | 0 | 4,210,657 | 4,210,657 |
8. | Rommel et al. [18] | Incidence | GBD-2017 | 2033 | 303,608 | 305,641 |
9. | Gianino et al. [19] | Incidence | GBD-2019 | 17,105 | 835,685 | 852,790 |
10. | Salinas-Escudero et al. [20] | Incidence | GBD-2010 | 39,202 | 2,126,222 | 2,165,424 |
11. | Singh et al. [21] | Incidence | GBD-2019 | 112, 803 | 13,987,619 | 14,100,422 |
12. | Jo et al. [22] | Incidence | GBD-2018 | 260.3 | 2270.7 | 2531 |